Clinical trial
PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.
NCT06220370 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.
- Lead sponsor
- Kirby Institute
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 1, 2024
- Completion date
- March 1, 2029
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
infection, bacterial, infection, fungal, infection, soft tissue, injection site infection, invasive bacterial infection, invasive fungal infections